Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Journal of Pharmacology and PharmacotherapeuticsNOW IN
    Article

    Effect of Atorvastatin and Rosuvastatin on the Glycemic Control in Patients with Type II Diabetes Mellitus: A Comparative, Randomized, Double-Blind Study

    Mohini Sachin Mahatme1, Mukunda Bharat Bargade1★, Sachin K. Hiware1, M. M. Motlag2★ Corresponding author

    1. 1Department of Pharmacology, Indira Gandhi Government Medical College, Nagpur, Maharashtra, India.
    2. 2Department of Medicine, Indira Gandhi Government Medical College, Nagpur, Maharashtra, India.

    CORRESPONDENCE

    Mukunda Bharat Bargade

    Department of Pharmacology, Indira Gandhi Government Medical College, Nagpur, Maharashtra, India.

    mukundagmc@gmail.com

    Received: 22-01-2021; Revised: 15-05-2021; Accepted: 22-05-2021.

    Volume 12, Issue 2 · pp. 54–60 · PUBLISHED 17 September 2021 · DOI: 10.4103/jpp.jpp_8_21

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    Objectives: To compare the effects of atorvastatin and rosuvastatin in type II diabetes mellitus (T2DM) patients with dyslipidemia. Materials and Methods: Eighty patients with history of T2DM of more than 3 months duration, glycated hemoglobin <7%, dyslipidemia, and normal electrocardiogram were included in the randomized double‑blind trial. The patients received either tablet atorvastatin 20 mg or rosuvastatin 10 mg once a day along with metformin and glimepiride twice daily orally. Patients were evaluated by the change in estimated average glucose (eAG), lipid profile, and incidence of adverse drug reactions (ADRs). Results: Rise in fasting blood sugar (FBS), postprandial blood sugar, and eAG were significant in the atorvastatin group as compared to the rosuvastatin group where there was a significant increase only in FBS levels. Changes in lipid parameters and incidence of ADR were similar in both the groups. Conclusion: Rosuvastatin can be preferred to atorvastatin in T2DM with dyslipidemia due to less variation in the blood sugar parameters, effective control over lipid profile, pleiotropic effects, and less microsomal interactions.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Mahatme, M. S., Bargade, M. B., Hiware, S. K., & Motlag, M. M. (2021). Effect of Atorvastatin and Rosuvastatin on the Glycemic Control in Patients with Type II Diabetes Mellitus: A Comparative, Randomized, Double-Blind Study. Journal of Pharmacology and Pharmacotherapeutics, 12(2), 54–60. https://doi.org/10.4103/jpp.jpp_8_21